Phase I/II study of stereotactic radiotherapy for renal cell cancer

Phase I/II study of stereotactic radiotherapy for renal cell cancer - Stereotactic radiotherapy for renal cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004172

Enrollment

Registered

2010-09-08

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal cell cancer

Interventions

perform stereotactic radiotherapy for renal cancer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: histologically or clinically diagnosed renal cell cancer

Exclusion criteria

Exclusion criteria: female during pregnancy active duplicated malignancy

Design outcomes

Primary

Measure	Time frame
toxicity 3-year local progression-free rate	—

Secondary

Measure	Time frame
3-year overall survival rate local response progression-free survival time median survival time locally progression-free time failure pattern	—

Countries

Japan

Contacts

Public ContactHiroshi Onishi

University of Yamanashi Department of Radiology

honishi@yamanashi.ac.jp055-273-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026